Expanded subpopulation of FoxP3+ T regulatory cells in renal cell carcinoma co-express Helios, indicating they could be derived from natural but not induced Tregs

被引:38
作者
Elkord, Eyad [1 ,2 ]
Sharma, Smita [2 ]
Burt, Deborah J. [2 ]
Hawkins, Robert E. [2 ]
机构
[1] Univ Salford, Ctr Biochem Drug Design & Canc Res, Sch Environm & Life Sci, Salford M5 4WT, Lancs, England
[2] Univ Manchester, Manchester Acad Hlth Sci Ctr, Dept Med Oncol, Sch Canc & Enabling Sci, Manchester M20 4BX, Lancs, England
关键词
FoxP3; Helios; Natural Tregs; Induced Tregs; Renal cell carcinoma; HIGH-DOSE INTERLEUKIN-2; CANCER; IL-2; IMMUNOTHERAPY; TOLERANCE; FREQUENCY; MELANOMA;
D O I
10.1016/j.clim.2011.04.014
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Conversion of conventional T cells into T regulatory cells (Tregs) has been proposed as a potential mechanism for Treg expansion in cancer. However, this evidence is supported by in vitro or mouse model studies with no data from in vivo or human studies to support its rote in enriching peripheral and tumor-infiltrating Tregs. Recent work has shown that induced FoxP3(+) Tregs (iTregs) do not express Helios; an Ikaros family transcription factor. We analyzed peripheral blood samples from untreated renal cell carcinoma (RCC) patients and following interleukin (IL)-2 treatment for the expression of FoxP3 and Helios. Our work shows that expanded peripheral FoxP3(+) Tregs in untreated RCC patients co-express Helios. Interestingly, IL-2 administration results in expansion of FoxP3(+)Helios(+) natural Tregs (nTregs) significantly more than FoxP3(+)Helios(-) iTregs. Our work shows that the increased FoxP3(+) Treg subpopulation in RCC patients co-express Helios, indicating that they could be derived from natural but not induced Tregs. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:218 / 222
页数:5
相关论文
共 24 条
  • [1] IL-2 administration increases CD4+CD25hi Foxp3+ regulatory T cells in cancer patients
    Ahmadzadeh, M
    Rosenberg, ST
    [J]. BLOOD, 2006, 107 (06) : 2409 - 2414
  • [2] Characterization of CD4+CD25+ regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma
    Cesana, GC
    DeRaffele, G
    Cohen, S
    Moroziewicz, D
    Mitcham, J
    Stoutenburg, J
    Cheung, K
    Hesdorffer, C
    Kim-Schulze, S
    Kaufman, HL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (07) : 1169 - 1177
  • [3] Natural and Adaptive Foxp3+ Regulatory T Cells: More of the Same or a Division of Labor?
    de Lafaille, Maria A. Curotto
    Lafaille, Juan J.
    [J]. IMMUNITY, 2009, 30 (05) : 626 - 635
  • [4] T regulatory cells in cancer: recent advances and therapeutic potential
    Elkord, Eyad
    Alcantar-Orozco, Erik M.
    Dovedi, Simon J.
    Tran, Dat Q.
    Hawkins, Robert E.
    Gilham, David E.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (11) : 1573 - 1586
  • [5] Frequency of human T regulatory cells in peripheral blood is significantly reduced by cryopreservation
    Elkord, Eyad
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 2009, 347 (1-2) : 87 - 90
  • [6] Foxp3 Programs the Development and Function of CD4+CD25+ Regulatory T Cells (Reprinted from vol 4, pg 330-336, 2003)
    Fontenot, Jason D.
    Gavin, Marc A.
    Rudensky, Alexander Y.
    [J]. JOURNAL OF IMMUNOLOGY, 2017, 198 (03) : 986 - 992
  • [7] The Influence of Excessive IL-6 Production In Vivo on the Development and Function of Foxp3+ Regulatory T Cells
    Fujimoto, Minoru
    Nakano, Mayumi
    Terabe, Fumitaka
    Kawahata, Hirohisa
    Ohkawara, Tomoharu
    Han, Yongmei
    Ripley, Barry
    Serada, Satoshi
    Nishikawa, Teppei
    Kimura, Akihiro
    Nomura, Shintaro
    Kishimoto, Tadamitsu
    Naka, Tetsuji
    [J]. JOURNAL OF IMMUNOLOGY, 2011, 186 (01) : 32 - 40
  • [8] A role for the transcription factor Helios in human CD4+CD25+ regulatory T cells
    Getnet, Derese
    Grosso, Joseph F.
    Goldberg, Monica V.
    Harris, Timothy J.
    Yen, Hung-Rong
    Bruno, Tullia C.
    Durham, Nicholas M.
    Hipkiss, Edward L.
    Pyle, Kristin J.
    Wada, Satoshi
    Pan, Fan
    Pardoll, Drew M.
    Drake, Charles G.
    [J]. MOLECULAR IMMUNOLOGY, 2010, 47 (7-8) : 1595 - 1600
  • [9] Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival
    Griffiths, Richard W.
    Elkord, Eyad
    Gilham, David E.
    Ramani, Vijay
    Clarke, Noel
    Stern, Peter L.
    Hawkins, Robert E.
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2007, 56 (11) : 1743 - 1753
  • [10] Analysis of the T-Cell Receptor Repertoires of Tumor-Infiltrating Conventional and Regulatory T Cells Reveals No Evidence for Conversion in Carcinogen-Induced Tumors
    Hindley, James P.
    Ferreira, Cristina
    Jones, Emma
    Lauder, Sarah N.
    Ladell, Kristin
    Wynn, Katherine K.
    Betts, Gareth J.
    Singh, Yogesh
    Price, David A.
    Godkin, Andrew J.
    Dyson, Julian
    Gallimore, Awen
    [J]. CANCER RESEARCH, 2011, 71 (03) : 736 - 746